Market research
PRM.TO Big Pharma Split Corp
TO CAD Financial Services
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 19M
- P/E ratio
- Not available
- Analyst target
- 2
- Dividend yield
- 8.5%
- Beta
- 0.73
Community
Investor discussion
1 comment
Sign in to join the PRM.TO discussion.
5 years, 6 months ago
Big Pharma Split Corp is currently in a long term uptrend where the price is trading 10.5% above its 200 day moving average.
From a valuation standpoint, the stock is 15.3% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 23.2.
Based on the above factors, Big Pharma Split Corp gets an overall score of 2/5.